Citazione APA

Duska, L. R., Blessing, J. A., Rotmensch, J., Mannel, R. S., Hanjani, P., Rose, P. G., & Dizon, D. S. (2014). A Phase II Evaluation of Ixabepilone (IND #59699, NSC #710428) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol.

Stile di citazione Chicago

Duska, Linda R., John A. Blessing, Jacob Rotmensch, Robert S. Mannel, Parviz Hanjani, Peter G. Rose, e Don S. Dizon. "A Phase II Evaluation of Ixabepilone (IND #59699, NSC #710428) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2014.

Citazione MLA

Duska, Linda R., et al. "A Phase II Evaluation of Ixabepilone (IND #59699, NSC #710428) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2014.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.